Abstract:Objective The usefulness of low-dose infusion of vasopressin in patients having left ventricle(LV) dysfunction undergoing cardiac surgery with cardiopulmonary bypass(CPB) is not well studied. Our study aimed to evaluate the hemodynamic and clinical effects of low-dose vasopressin infusion in this patient population. Our primary hypothesis is that vasopressin infusion reduces the cardiac index measured at the end of CPB. Design and method This randomised double-blinded controlled trial was conducted in 36 patients of age above 18 years, planned for elective cardiac surgery with CPB and presenting with LV dysfunction preoperatively. Patients in the vasopressin group (n=18) received 1.2 units per hour of vasopressin infusion started at the end of CPB while patients in the control group (n=18) received normal saline. Hemodynamic parameters, blood gas analyses, and echocardiographic estimates of cardiac output were collected at baseline, 30 minutes post-CPB, at receiving in the Intensive Care Unit (ICU), and 6,12 and 24 hours after receiving in the ICU. The primary outcome was the cardiac index in the two groups at 30 minutes post-CPB. Results and conclusions Cardiac index at 30 minutes post-CPB was not statistically significantly different between the two groups(3.22±1.44 l/minute/m2 in the vasopressin group vs. 2.64±0.88 l/minute/m2 in the control group, P=0.157).The heart rate and MAP were statistically significantly higher in the vasopressin group than the control group at 6 hours after receiving in ICU (102.55±17.92 vs. 86.67±15.15 beats per minute, P=0.007 and 72.50±8.60 vs. 66.17±9.08mm Hg, P=0.039, respectively). The diastolic blood pressure was statistically significantly higher in the vasopressin group than the control group at 12 and 24 hours after receiving in ICU (69.64±8.08 vs. 63.88±8.2 mm Hg, P=0.044 at 12 hours and 70.17±6.44 vs. 61.72±5.85mm Hg, P=0.001 at 24 hours). There was no statistically significant difference in the serum lactate, mixed venous oxygen saturation and delta-partial pressure of carbon dioxide between the two groups at any time. The fluid balance at 24 hours was statistically significantly lower in the vasopressin group than in the control group (15.20±27.77 vs. 34.69±12.60 ml/kg, respectively, P=0.11). The two groups had no statistically significant difference in the mechanical ventilation duration, ICU stay and 30-day outcome. No patient developed new-onset atrial fibrillation in the postoperative period in either group.The results of the present study indicate that the use of low dose vasopressin infusion in cardiac surgical patients with left ventricle dysfunction may not reduce the cardiac index at the end of cardiopulmonary bypass. Vasopressin infusion does not affect the clinical surrogates of cardiac output and clinical outcomes.

Desmopressin use in major cardiac surgery is associated with renal impairment: a retrospective single-center analysis

Desmopressin to reduce periprocedural bleeding and transfusion: a systematic review and meta-analysis

Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience

Safety and efficacy of desmopressin (DDAVP) in preventing hematoma expansion in intracranial hemorrhage associated with antiplatelet drugs use: A systematic review and metaanalysis

Role of desmopressin in reducing blood loss following breast cancer radical operation

Low Dose Vasopressin Infusion Post-Cardiopulmonary Bypass In Patients With Left Ventricular Dysfunction: A Randomized Controlled Trial

Postoperative Diastolic Perfusion Pressure is Associated with the Development of Acute Kidney Injury in Patients after Cardiac Surgery: a Retrospective Analysis

Perfusion parameters during cardiopulmonary bypass as a predictor of acute kidney injury after aortic valve replacement

Pre- and/or Intra-Operative Prescription of Diuretics, but Not Renin-Angiotensin-System Inhibitors, Is Significantly Associated with Acute Kidney Injury after Non-Cardiac Surgery: A Retrospective Cohort Study

Desmopressin dosing in children using real-world data and pharmacokinetic/pharmacodynamic model simulations

Effect of dopamine in preventing postoperative acute kidney injury after cardiac surgery in patients with elevated baseline serum creatinine

Role of Desmopressin Acetate before Percutaneous Ultrasound-Guided Kidney Biopsy in Patients with Kidney Dysfunction

Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial

Prospective randomized double-blind study to evaluate the superiority of Vasopressin versus Norepinephrine in the management of the patient at renal risk undergoing cardiac surgery with cardiopulmonary bypass (NOVACC trial)

Reduction in acute kidney injury post cardiac surgery using balanced forced diuresis: a randomized, controlled trial

Renal tissue desaturation and acute kidney injury in infant cardiac surgery: a prospective propensity score-matched cohort study

Hemodynamic Changes in Intrarenal Blood Flow are Associated With Poor Prognosis in Patients With Acute Decompensated Heart Failure

Perioperative Left Ventricular Assist Device Use in Patients With Reduced Ejection Fraction Reduces Cardiac Surgery-Associated Acute Kidney Injury

Clinical and Operative Determinants of Acute Kidney Injury after Cardiac Surgery

Vacuum-assisted Venous Drainage in Adult Cardiac Surgery: a Propensity-Matched Study

Dexmedetomidine Mitigates Acute Kidney Injury after Coronary Artery Bypass Grafting: a Prospective Clinical Trial.